Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions for the life sciences industry, has announced new appointments to its leadership team. Alicia Staley has been named Chief Patient Officer and Senior Vice President of Social Impact and Engagement, Lisa Moneymaker as Senior Vice President of Strategic Customer Engagement, and Chris King as Senior Vice President and Head of Customer Success, Services, and Support. In these roles, they will focus on prioritizing the needs of patients and customers, bringing empathy, expertise, and innovative solutions to enhance their experiences. By championing these values, they will advance mission to drive smarter treatments and healthier outcomes.
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions for the life sciences industry, has appointed three new leaders to its executive team to strengthen its patient-centered and customer-focused mission. Alicia Staley has been named Chief Patient Officer and Senior Vice President of Social Impact and Engagement, Lisa Moneymaker has joined as Senior Vice President of Strategic Customer Engagement, and Chris King will serve as Senior Vice President and Head of Customer Success, Services, and Support.
These key appointments are part of continued efforts to enhance patient and customer experiences by addressing their needs with empathy, innovation, and proactive solutions. Each leader brings significant expertise and a passion for improving healthcare outcomes, further driving Medidata’s mission to support clinical trials with smarter treatments and healthier people.
As the Chief Patient Officer, Staley will continue her work of integrating the patient perspective into Medidata’s solutions. With her extensive experience in software design and information systems management, Staley has already been instrumental in shaping the company’s approach to patient-centricity. Since joining in 2018, she established the Patient Insights Board, an initiative that ensures patient needs are central to software development and clinical research processes. By continuing to represent the patient voice, Staley will help ensure that Medidata’s products and services are better aligned with patients’ priorities and concerns, ultimately improving the patient experience in clinical trials.
Moneymaker, with nearly 25 years of experience at the crossroads of technology and clinical research, will lead efforts to build stronger customer relationships. In her new role as Senior Vice President of Strategic Customer Engagement, she will foster a culture of active listening and anticipate customers’ needs. Moneymaker’s background in pharma, biotech, and medical devices equips her with the knowledge and insights needed to better serve Medidata’s diverse clientele. Her focus will be on nurturing customer partnerships and ensuring that Medidata’s solutions effectively address the challenges faced by pharmaceutical and biotech companies in conducting clinical trials.
King brings over 25 years of expertise in customer success, most recently serving as Senior Vice President of Professional Services at Salesforce. In his new role as Senior Vice President of Customer Success, Services, and Support, King will be responsible for guiding customers through every step of their engagement with Medidata, from initial adoption through to continued support and satisfaction. By enhancing Medidata’s customer service capabilities, King will help ensure that clients receive the maximum value from the company’s solutions, further improving overall satisfaction and retention.
The leadership appointments come at a time when Medidata is focused on growing its global presence and reinforcing its position as an industry leader in clinical trials. Anthony Costello, CEO of Medidata, highlighted the importance of these roles in achieving the company’s mission to enhance patient and customer experiences. “Our mission to enhance the patient and customer experience requires executives who deeply understand their challenges and priorities,” Costello said. “Alicia, Lisa, and Chris bring decades of expertise and a passion for innovation that will help us deliver solutions that truly make a difference for patients and customers around the world.”
Staley’s, Moneymaker’s, and King’s combined decades of experience will contribute to Medidata’s ongoing success. Staley’s background in information systems, Moneymaker’s leadership in clinical research, and King’s proficiency in customer success will empower Medidata to continue its innovative work in clinical trials, particularly in streamlining processes and improving patient engagement.
Medidata has been a trailblazer in supporting clinical trials through digital solutions, celebrating 25 years of ground-breaking innovation. The company’s comprehensive platform is used across more than 35,000 trials and has supported 10 million patients. With a wealth of industry-leading expertise and analytics-powered insights, Medidata is trusted by over 1 million registered users, including approximately 2,300 customers globally. The company is known for offering the largest patient-level historical clinical trial data set in the world, further strengthening its role in advancing clinical research.
As a leader in the life sciences industry, Medidata’s platform has empowered customers to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. Medidata is a recognized Leader in the field by both Everest Group and IDC.
Medidata’s parent company, Dassault Systèmes, continues to be a catalyst for human progress, pioneering virtual solutions to improve real-life outcomes for consumers, patients, and citizens. Through the 3DEXPERIENCE platform, Dassault Systèmes supports 350,000 customers across various industries to collaborate, innovate, and create sustainable solutions that drive meaningful impact.
About Medidata
Medidata is a leading provider of digital solutions supporting clinical trials. Through its platform, Medidata is transforming clinical trials to power smarter treatments and healthier people. Medidata is trusted by over 1 million users and provides the largest patient-level historical clinical trial data set in the world. With over 25 years of experience, Medidata accelerates clinical breakthroughs, improves patient experiences, and supports the faster delivery of therapies to market.
About Dassault Systèmes
Dassault Systèmes is a pioneer in virtual solutions that improve real-life outcomes. The company’s 3DEXPERIENCE platform empowers customers to drive innovation across industries, enabling the creation of sustainable solutions with a meaningful impact.
